Location History:
- Belle Mead, NJ (US) (2010)
- Jiangsu, CN (2017 - 2020)
- Shanghai, CN (2022)
Company Filing History:
3 out of 7 
1 out of 25 
1 out of 1 Years Active: 2010-2022
Title: Zelin Sheng: Innovator in Pharmaceutical Chemistry
Introduction
Zelin Sheng is a prominent inventor based in Jiangsu, China, known for his significant contributions to pharmaceutical chemistry. He holds a total of four patents, showcasing his innovative approach to drug development and therapeutic solutions.
Latest Patents
Sheng's latest patents include groundbreaking work on cycloalkyl and hetero-cycloalkyl inhibitors. These patents describe compounds that selectively inhibit KRAS, demonstrating improved pharmacodynamic and pharmacokinetic performance while reducing toxic side effects. Additionally, he has developed deuterated chenodeoxycholic acid derivatives, which are used in pharmaceutical compositions to treat diseases related to the farnesoid X receptor and G-protein coupled bile acid receptor, such as nonalcoholic steatohepatitis and primary biliary cirrhosis.
Career Highlights
Throughout his career, Zelin Sheng has worked with notable companies, including Suzhou Zelgen Biopharmaceuticals Co., Ltd. and Theracos, Inc. His work in these organizations has significantly advanced the field of biopharmaceuticals, particularly in the development of innovative therapeutic agents.
Collaborations
Sheng has collaborated with esteemed colleagues, including Binhua Lv and Yuanwei Chen, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Zelin Sheng's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to impact the development of new therapies for various diseases, showcasing the importance of innovation in healthcare.